Scientists find natural compounds that hit COVID-19 from every angle – Image for illustrative purposes only (Image credits: Unsplash)
Researchers have uncovered a set of natural compounds in the leaves of a little-known tree native to Brazil’s Atlantic Forest. These galloylquinic acids appear capable of interfering with SARS-CoV-2 through several distinct biological pathways at once. The discovery points to a possible new direction in antiviral research that could complicate the virus’s ability to develop resistance.
Origin of the Compounds
The tree grows in the remaining fragments of Brazil’s Atlantic Forest, a biodiversity hotspot that has lost most of its original coverage. Scientists extracted the galloylquinic acids directly from its leaves and tested them against the virus in laboratory settings. The compounds stood out because they are produced naturally by the plant rather than synthesized in a lab.
Initial screening showed activity against the virus that exceeded expectations for a single plant extract. The work focused on isolating these specific molecules and confirming their presence in the tree’s foliage. Further chemical analysis revealed their structure and confirmed they belong to a class of polyphenols known for various biological effects.
Three Distinct Ways They Interfere With the Virus
The galloylquinic acids disrupt SARS-CoV-2 at different stages of its life cycle. One action prevents the virus from attaching to and entering human cells. A second action interferes with the virus’s ability to copy its genetic material inside infected cells. A third action reduces the inflammatory response that can worsen illness in some patients.
Because the compounds act on multiple targets simultaneously, the virus would need to mutate in several places at once to evade them. This multi-pronged effect differs from many existing antivirals that focus on a single viral protein. Laboratory tests indicated measurable reductions in viral load and inflammation markers when the compounds were present.
Key mechanisms observed:
- Blocks viral entry into cells
- Disrupts replication inside cells
- Lowers harmful inflammation
Implications for Antiviral Development
Current antiviral strategies often rely on drugs that hit one part of the virus, which can allow resistant variants to emerge quickly. The natural compounds from the Brazilian tree offer a different profile by addressing entry, replication, and inflammation together. This combination could make it harder for the virus to adapt while also addressing symptoms driven by excessive immune response.
Researchers note that these findings come from controlled laboratory experiments and have not yet been tested in clinical settings. Additional studies will be needed to determine safety, effective doses, and whether the compounds can be produced at scale. The work adds to growing interest in plant-derived molecules as starting points for new medicines.